{"DataElement":{"publicId":"2189871","version":"1","preferredName":"Laboratory Assay Method Name","preferredDefinition":"Name of the method of measuring the pharmacologic (PK) effects of a biologically active substance using an intermediate in vivo or in vitro tissue or cell model under controlled conditions.","longName":"LAB_ASSAY_METH_NM","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"2014467","version":"1","preferredName":"Laboratory techniques","preferredDefinition":"Techniques used in laboratory for research purposes. NCI Metathesaurus code: CL026563","longName":"LAB_TECHNIQUES","context":"SPOREs","contextVersion":"2.31","ObjectClass":{"publicId":"2177214","version":"1","preferredName":"Laboratory","preferredDefinition":"Laboratory; a workplace for the conduct of scientific research.","longName":"Laboratory","context":"SPOREs","contextVersion":"2.31","Concepts":[{"longName":"Laboratory","conceptCode":"C37984","definition":"A facility equipped and competent to conduct scientific experiments, observations, tests, investigations, and/or to manufacture chemicals or medical products.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCB123AF-4560-424A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-05-02","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-05-02","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":"updated to add concept code. dw","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177689","version":"1","preferredName":"Techniques","preferredDefinition":"Scientific or clinical procedures and methods.","longName":"Techniques","context":"SPOREs","contextVersion":"2.31","Concepts":[{"longName":"Technique","conceptCode":"C16847","definition":"A practiced and regimented skill or series of actions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCB092FB-CFEE-4242-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-05-02","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-05-02","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":"Added Concept Code AA","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008509","version":"2.31","preferredName":"SPOREs","preferredDefinition":"A Conceptual Domain to capture value meanings specfic to SPOREs not suitable for placement elsewhere.","longName":"SPORES","context":"SPOREs","contextVersion":"2.31","origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"99BA9DC8-209A-4E69-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":"Changed name to match Context per Hvroje Med.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B80FC2BC-5293-006B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-03-04","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-03-04","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2189869","version":"1","preferredName":"Laboratory Assay Method Name","preferredDefinition":"Name of the method of measuring the effects of a biologically active substance using an intermediate in vivo or in vitro tissue or cell model under controlled conditions.","longName":"LAB_ASSAY_METH_NM","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"40","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"ER","valueDescription":"Estrogen Receptor","ValueMeaning":{"publicId":"2572015","version":"1","preferredName":"Estrogen Receptor","longName":"2572015","preferredDefinition":"Widely expressed human Estrogen Receptors (NR3 Family) are cytoplasmic hormone-activated receptors that act as nuclear transcription factors composed of an N-terminal transcription activation/modulation domain, a DNA-binding domain, and a C-terminal steroid-binding domain. Binding to DNA as a homo- or heterodimer, ESR interacts with NCOA3, NCOA5, and NCOA6 coactivators. Hormone-ESR complexes appear to recognize discrete upstream target ERE DNA sequences to regulate gene expression, cell proliferation, and differentiation. DNA-binding is lost in the absence of ligand. (NCI)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Estrogen Receptor Family","conceptCode":"C17069","definition":"Widely expressed human Estrogen Receptors (NR3 Family) are cytoplasmic hormone-activated receptors that act as nuclear transcription factors composed of an N-terminal transcription activation/modulation domain, a DNA-binding domain, and a C-terminal steroid-binding domain. Binding to DNA as a homo- or heterodimer, ESR interacts with NCOA3, NCOA5, and NCOA6 coactivators. Hormone-ESR complexes appear to recognize discrete upstream target ERE DNA sequences to regulate gene expression, cell proliferation, and differentiation. DNA-binding is lost in the absence of ligand. (NCI)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E65C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-10-13","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E5F32266-BC9A-1A1E-E034-0003BA3F9857","beginDate":"2004-10-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-10-13","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"PR","valueDescription":"Progesterone Receptor","ValueMeaning":{"publicId":"2572016","version":"1","preferredName":"Progesterone Receptor","longName":"2572016","preferredDefinition":"Progesterone Receptor Assay","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E65D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-10-13","modifiedBy":"REEVESD","dateModified":"2004-10-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E5F32266-BC9B-1A1E-E034-0003BA3F9857","beginDate":"2004-10-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-10-13","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"p53","valueDescription":"p53 Assay","ValueMeaning":{"publicId":"2572017","version":"1","preferredName":"p53 Assay","longName":"2572017","preferredDefinition":"p53 Assay","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E65E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-10-13","modifiedBy":"REEVESD","dateModified":"2004-10-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E5F32266-BC9C-1A1E-E034-0003BA3F9857","beginDate":"2004-10-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-10-13","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"HER-2 (IHC)","valueDescription":"Her-2, Immunohistochemistry","ValueMeaning":{"publicId":"2572018","version":"1","preferredName":"Her-2, Immunohistochemistry","longName":"2572018","preferredDefinition":"Her-2, Immunohistochemistry Assay","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E65F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-10-13","modifiedBy":"REEVESD","dateModified":"2004-10-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E5F32266-BC9D-1A1E-E034-0003BA3F9857","beginDate":"2004-10-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-10-13","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"HER-2 (ISH)","valueDescription":"Her-2, In Situ Hybridization","ValueMeaning":{"publicId":"2572019","version":"1","preferredName":"Her-2, In Situ Hybridization","longName":"2572019","preferredDefinition":"Her-2, In Situ Hybridization Assay","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E660-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-10-13","modifiedBy":"REEVESD","dateModified":"2004-10-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E5F32266-BC9E-1A1E-E034-0003BA3F9857","beginDate":"2004-10-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-10-13","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"PKs","valueDescription":"Pharmacokinetics","ValueMeaning":{"publicId":"2562229","version":"1","preferredName":"Pharmacokinetics","longName":"2562229","preferredDefinition":"Pharmacokinetics","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pharmacokinetics","conceptCode":"C15299","definition":"The characteristic movements of drugs within biological systems, as affected by absorption, distribution, binding, elimination, biotransformation, and excretion; particularly the rates of such movements.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C022-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-02","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-08-02","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"371D9726-824C-1E6C-E044-0003BA3F9857","beginDate":"2007-08-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-08-07","modifiedBy":"REEVESD","dateModified":"2007-08-07","deletedIndicator":"No"},{"value":"ELISA","valueDescription":"ELISA","ValueMeaning":{"publicId":"2558713","version":"1","preferredName":"ELISA","longName":"2558713","preferredDefinition":"ELISA","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ELISA","conceptCode":"C16553","definition":"A highly sensitive technique for detecting and measuring antigens or antibodies in a solution; the solution is run over a surface to which immobilized antibodies specific to the substance have been attached, and if the substance is present, it will bind to the antibody layer, and its presence is verified and visualized with an application of antibodies that have been tagged in some way. (BioTech Life Science Dictionary)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B266-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"371D9726-8259-1E6C-E044-0003BA3F9857","beginDate":"2007-08-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-08-07","modifiedBy":"REEVESD","dateModified":"2007-08-07","deletedIndicator":"No"},{"value":"Sequencing","valueDescription":"Nucleic Acid Sequencing","ValueMeaning":{"publicId":"3339147","version":"1","preferredName":"Nucleic Acid Sequencing","longName":"3339147","preferredDefinition":"The process of determining the sequence of purines and pyrimidines in nucleic acids and polynucleotides.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nucleic Acid Sequencing","conceptCode":"C18881","definition":"The process of determining the sequence of purines and pyrimidines in nucleic acids and polynucleotides.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CBC6F0-0A13-06B9-E040-BB89AD434070","latestVersionIndicator":"Yes","beginDate":"2011-12-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DA6B88D3-FF88-A225-E040-BB89AD43361D","beginDate":"2013-04-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-04-15","modifiedBy":"ONEDATA","dateModified":"2013-04-15","deletedIndicator":"No"},{"value":"Multiplex Immunoassay","valueDescription":"Multiple Immunologic Technique","ValueMeaning":{"publicId":"3727152","version":"1","preferredName":"Multiple Immunologic Technique","longName":"3727152","preferredDefinition":"Having, relating to, or consisting of more than one individual, element, part, or other component; manifold. (dictionary.com): Laboratory technique involving interaction of antigens with specific antibodies.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiple","conceptCode":"C17648","definition":"Having, relating to, or consisting of more than one individual, element, part, or other component; manifold.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunology Test","conceptCode":"C16723","definition":"Laboratory test involving interaction of antigens with specific antibodies.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DA6B88D3-FF5B-A225-E040-BB89AD43361D","latestVersionIndicator":"Yes","beginDate":"2013-04-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-04-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DA6B88D3-FF74-A225-E040-BB89AD43361D","beginDate":"2013-04-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-04-15","modifiedBy":"ONEDATA","dateModified":"2013-04-15","deletedIndicator":"No"},{"value":"Unspecified","valueDescription":"Unspecified","ValueMeaning":{"publicId":"2573360","version":"1","preferredName":"Unspecified","longName":"2573360","preferredDefinition":"Not stated explicitly or in detail.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unspecified","conceptCode":"C38046","definition":"Not stated explicitly or in detail.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EB9D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"KLINGERK","dateCreated":"2005-03-06","modifiedBy":"TSESU","dateModified":"2023-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DA6B88D3-FF7E-A225-E040-BB89AD43361D","beginDate":"2013-04-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-04-15","modifiedBy":"ONEDATA","dateModified":"2013-04-15","deletedIndicator":"No"},{"value":"Proliferation Assay","valueDescription":"Proliferation Assay","ValueMeaning":{"publicId":"3727153","version":"1","preferredName":"Proliferation Assay","longName":"3727153","preferredDefinition":"Multiplying or increasing in number.  In biology, cell proliferation occurs by a process known as cell division.: A qualitative or quantitative analysis performed to determine the amount of a particular constituent in a sample or the biological or pharmacological potency of a drug.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Proliferation","conceptCode":"C28378","definition":"Multiplying or increasing in number.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assay","conceptCode":"C60819","definition":"A qualitative or quantitative analysis performed to determine the amount of a particular constituent in a sample or the biological or pharmacological properties of a drug.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DA6B88D3-FF93-A225-E040-BB89AD43361D","latestVersionIndicator":"Yes","beginDate":"2013-04-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-04-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DA6B88D3-FFAC-A225-E040-BB89AD43361D","beginDate":"2013-04-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-04-15","modifiedBy":"ONEDATA","dateModified":"2013-04-15","deletedIndicator":"No"},{"value":"RT-PCR","valueDescription":"RT-PCR","ValueMeaning":{"publicId":"3121570","version":"1","preferredName":"RT-PCR","longName":"3121570","preferredDefinition":"RT-PCR is short for reverse transcriptase-polymerase chain reaction. It is a technique in which an RNA strand is first transcribed into a DNA complement and then subjected to PCR amplification. Transcribing an RNA strand into a DNA complement is termed reverse transcription and is done by the enzyme reverse transcriptase. (from Wikipedia)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reverse Transcriptase-Polymerase Chain Reaction","conceptCode":"C18136","definition":"A laboratory procedure in which an RNA strand is first transcribed into a DNA complement and then subjected to PCR amplification. Transcribing an RNA strand into a DNA complement is termed reverse transcription and is done by the enzyme reverse transcriptase.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B5C8518-E9B3-522C-E040-BB89AD43153D","latestVersionIndicator":"Yes","beginDate":"2010-07-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-07-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DA6B88D3-FFB6-A225-E040-BB89AD43361D","beginDate":"2013-04-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-04-15","modifiedBy":"ONEDATA","dateModified":"2013-04-15","deletedIndicator":"No"},{"value":"Real Time-PCR","valueDescription":"Real Time PCR","ValueMeaning":{"publicId":"3727155","version":"1","preferredName":"Real Time PCR","longName":"3727155","preferredDefinition":"A modified polymerase chain reaction (PCR) technique in which DNA amplification is detected and quantified as the PCR reaction progresses, through the use of fluorescent DNA probes in the reaction mixture.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Real Time PCR","conceptCode":"C51962","definition":"An application of PCR that measures the products generated during each cycle of the polymerase chain reaction process in order to determine the starting amount of template in the reaction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DA6B88D3-FFC3-A225-E040-BB89AD43361D","latestVersionIndicator":"Yes","beginDate":"2013-04-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-04-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DA6B88D3-FFDC-A225-E040-BB89AD43361D","beginDate":"2013-04-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-04-15","modifiedBy":"ONEDATA","dateModified":"2013-04-15","deletedIndicator":"No"},{"value":"PCR","valueDescription":"Polymerase Chain Reaction","ValueMeaning":{"publicId":"3234683","version":"1","preferredName":"Polymerase Chain Reaction","longName":"3234683","preferredDefinition":"A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase.  This results in duplication of the targeted DNA region. Newly synthesized DNA strands can subsequently serve as additional templates for the same primer sequences, so that successive rounds of primer annealing, strand elongation, and dissociation produce rapid and highly specific amplification of the desired sequence. PCR also can be used to detect the existence of the defined sequence in a DNA sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Polymerase Chain Reaction","conceptCode":"C17003","definition":"A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase.  This results in duplication of the targeted DNA region. Newly synthesized DNA strands can subsequently serve as additional templates for the same primer sequences, so that successive rounds of primer annealing, strand elongation, and dissociation produce rapid and highly specific amplification of the desired sequence. PCR also can be used to detect the existence of the defined sequence in a DNA sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A3158B0D-1572-9FBA-E040-BB89AD431012","latestVersionIndicator":"Yes","beginDate":"2011-05-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-05-12","modifiedBy":"SOKKERL","dateModified":"2023-12-01","changeDescription":"7-20-20 TMT updated concept with NCIt definition.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DA6B88D3-FFE6-A225-E040-BB89AD43361D","beginDate":"2013-04-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-04-15","modifiedBy":"ONEDATA","dateModified":"2013-04-15","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DA6B88D3-FFF0-A225-E040-BB89AD43361D","beginDate":"2013-04-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-04-15","modifiedBy":"ONEDATA","dateModified":"2013-04-15","deletedIndicator":"No"},{"value":"Multiplex Immunoassay","valueDescription":"Multiplex Immunoassay","ValueMeaning":{"publicId":"3727156","version":"1","preferredName":"Multiplex Immunoassay","longName":"3727156","preferredDefinition":"Multiplex Immunoassay","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DA6B88D3-FFFA-A225-E040-BB89AD43361D","latestVersionIndicator":"Yes","beginDate":"2013-04-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-04-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DA6B88D4-0013-A225-E040-BB89AD43361D","beginDate":"2013-04-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-04-15","modifiedBy":"ONEDATA","dateModified":"2013-04-15","deletedIndicator":"No"},{"value":"Microarray","valueDescription":"Microarray","ValueMeaning":{"publicId":"2575508","version":"1","preferredName":"Microarray","longName":"2575508","preferredDefinition":"A microarray is a piece of glass or plastic on which different samples have been affixed at separate locations in an ordered manner thus forming a microscopic array.  The samples are usually DNA fragments but may also be antibodies, other proteins, or tissues.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Microarray","conceptCode":"C44282","definition":"A piece of glass or plastic on which different samples have been affixed at separate locations in an ordered manner thus forming a microscopic array.  The samples are usually DNA fragments but may also be antibodies, other proteins, or tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F401-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-06","endDate":null,"createdBy":"HARDINGR","dateCreated":"2005-07-06","modifiedBy":"CURTIST","dateModified":"2009-01-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DA6B88D4-001D-A225-E040-BB89AD43361D","beginDate":"2013-04-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-04-15","modifiedBy":"ONEDATA","dateModified":"2013-04-15","deletedIndicator":"No"},{"value":"Mass Spectrometry","valueDescription":"Mass Spectrometry","ValueMeaning":{"publicId":"3339145","version":"1","preferredName":"Mass Spectrometry","longName":"3339145","preferredDefinition":"An analytical technique wherein ions are separate according to their ratio of charge to mass. From the mass spectrum produced, the atomic weight of the particle can be deduced.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mass Spectrometry","conceptCode":"C17156","definition":"An analytical technique wherein ions are separated according to their ratio of charge to mass. From the mass spectrum produced, the atomic weight of the particle can be deduced.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CBC6F0-09E2-06B9-E040-BB89AD434070","latestVersionIndicator":"Yes","beginDate":"2011-12-23","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DA6B88D4-0028-A225-E040-BB89AD43361D","beginDate":"2013-04-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-04-15","modifiedBy":"ONEDATA","dateModified":"2013-04-15","deletedIndicator":"No"},{"value":"Microscopy/Imaging","valueDescription":"Microscopy Imaging Technique","ValueMeaning":{"publicId":"3684468","version":"1","preferredName":"Microscopy Imaging Technique","longName":"3684468","preferredDefinition":"The application of microscope magnification to the study of materials that cannot be properly seen by the unaided eye.: Any technology or method that aids in the visualization of any biological process, cell, tissue or organ for use in screening, diagnosis, surgical procedures or therapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Microscopy","conceptCode":"C16853","definition":"The use of various technologies to resolve the structure or features of objects too small or fine to naturally be seen by eye.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Imaging Technique","conceptCode":"C17369","definition":"Any technology or method that aids in the visualization of any biological process, cell, tissue or organ for use in screening, diagnosis, surgical procedures or therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D577786F-7B19-468E-E040-BB89AD430AE8","latestVersionIndicator":"Yes","beginDate":"2013-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-02-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DA6B88D4-01EA-A225-E040-BB89AD43361D","beginDate":"2013-04-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-04-15","modifiedBy":"ONEDATA","dateModified":"2013-04-15","deletedIndicator":"No"},{"value":"Immunohistochemistry (IHC)","valueDescription":"Immunohistochemistry Staining Method","ValueMeaning":{"publicId":"3031358","version":"1","preferredName":"Immunohistochemistry Staining Method","longName":"3031358","preferredDefinition":"Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunohistochemistry Staining Method","conceptCode":"C23020","definition":"Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"82F6B5AD-3994-79F8-E040-BB89AD430E7D","latestVersionIndicator":"Yes","beginDate":"2010-03-29","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-03-29","modifiedBy":"SOKKERL","dateModified":"2023-12-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DA6A9BDB-748D-B169-E040-BB89AD43700F","beginDate":"2013-04-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-04-15","modifiedBy":"ONEDATA","dateModified":"2013-04-15","deletedIndicator":"No"},{"value":"Flow Cytometry","valueDescription":"Flow Cytometry","ValueMeaning":{"publicId":"2974014","version":"1","preferredName":"Flow Cytometry","longName":"2974014","preferredDefinition":"A technique for counting, examining and sorting microscopic particles suspended in a stream of fluid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Flow Cytometry","conceptCode":"C16585","definition":"A technique for counting, examining and sorting microscopic particles suspended in a stream of fluid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BCD2B56-10AD-3667-E040-BB89AD436539","latestVersionIndicator":"Yes","beginDate":"2009-12-28","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-12-28","modifiedBy":"KUMMEROA","dateModified":"2022-06-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DA6A9BDB-7497-B169-E040-BB89AD43700F","beginDate":"2013-04-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-04-15","modifiedBy":"ONEDATA","dateModified":"2013-04-15","deletedIndicator":"No"},{"value":"in situ Hybridization","valueDescription":"in situ Hybridization","ValueMeaning":{"publicId":"2939763","version":"1","preferredName":"in situ Hybridization","longName":"2939763","preferredDefinition":"Use of a DNA or RNA probe to detect the presence of complementary sequences in chromosomes, cells, or tissues","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"In Situ Hybridization","conceptCode":"C17562","definition":"Use of a DNA or RNA probe to detect the presence of complementary sequences in chromosomes, cells, or tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"73532DB0-AF1C-0CB6-E040-BB89AD432D0F","latestVersionIndicator":"Yes","beginDate":"2009-09-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-09-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DA6A9BDB-7478-B169-E040-BB89AD43700F","beginDate":"2013-04-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-04-15","modifiedBy":"ONEDATA","dateModified":"2013-04-15","deletedIndicator":"No"},{"value":"ELISPOT","valueDescription":"Enzyme-linked Immunosorbent Spot Assay","ValueMeaning":{"publicId":"3645813","version":"1","preferredName":"Enzyme-linked Immunosorbent Spot Assay","longName":"3645813","preferredDefinition":"A highly sensitive immunoassay capable of detecting secreted materials from individual cells upon activation. If the material of interest is secreted in response to a particular stimulus, then the material will bind to a specific immobilized antibody. Binding is then verified and visualized by applying other antibodies that have been tagged in some way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Enzyme-linked Immunosorbent Spot Assay","conceptCode":"C102632","definition":"A highly sensitive immunoassay capable of detecting secreted materials from individual cells upon activation. If the material of interest is secreted in response to a particular stimulus, then the material will bind to a specific immobilized antibody. Binding is then verified and visualized by applying other antibodies that have been tagged in some way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D110A16D-2E14-9201-E040-BB89AD436122","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DA6A9BDB-74A2-B169-E040-BB89AD43700F","beginDate":"2013-04-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-04-15","modifiedBy":"ONEDATA","dateModified":"2013-04-15","deletedIndicator":"No"},{"value":"DAKO Herceptest","valueDescription":"Herceptest","ValueMeaning":{"publicId":"3718571","version":"1","preferredName":"Herceptest","longName":"3718571","preferredDefinition":"Test for identification of breast cancer patients with tumors that produce excessive amounts of the HER-2 protein.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HercepTest","conceptCode":"C25524","definition":"An FDA approved test for the evaluation of HER2 protein overexpression in breast tumors.  It provides semi-quantitative results of p185HER2 (HER2 gene) overexpression in Bouin or formalin-fixed, routinely processed, paraffin-embedded breast cancer tissues by light microscopy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D9D937BB-3A1B-8771-E040-BB89AD432B06","latestVersionIndicator":"Yes","beginDate":"2013-04-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2013-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DA6A9BDB-74AD-B169-E040-BB89AD43700F","beginDate":"2013-04-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-04-15","modifiedBy":"ONEDATA","dateModified":"2013-04-15","deletedIndicator":"No"},{"value":"Cytotoxicity Assay","valueDescription":"Cytotoxicity Assay","ValueMeaning":{"publicId":"3645809","version":"1","preferredName":"Cytotoxicity Assay","longName":"3645809","preferredDefinition":"The adverse effect of some iatrogenic therapies. It is an accepted side effect in radiation therapy where the desired effect is to kill rapidly growing tumor cells.  In the killing of tumor cells, other cells that are rapidly growing e.g hair, mucous membranes are also killed.: The determination of the amount of a particular constituent of a mixture or of the biological or pharmacological potency of a drug.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytotoxicity","conceptCode":"C27988","definition":"The adverse effect of some iatrogenic therapies. It is an accepted side effect in radiation therapy where the desired effect is to kill rapidly growing tumor cells.  In the killing of tumor cells, other cells that are rapidly growing e.g hair, mucous membranes are also killed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assay","conceptCode":"C60819","definition":"A qualitative or quantitative analysis performed to determine the amount of a particular constituent in a sample or the biological or pharmacological properties of a drug.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D110A16D-2DC7-9201-E040-BB89AD436122","latestVersionIndicator":"Yes","beginDate":"2012-12-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-12-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DA6A9BDB-74B8-B169-E040-BB89AD43700F","beginDate":"2013-04-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-04-15","modifiedBy":"ONEDATA","dateModified":"2013-04-15","deletedIndicator":"No"},{"value":"Western Blot (Immunoblot)","valueDescription":"Western Blotting","ValueMeaning":{"publicId":"2579450","version":"1","preferredName":"Western Blotting","longName":"2579450","preferredDefinition":"Identification of proteins or peptides that have been separated by gel electrophoresis and transferred (blotted) to strips of nitrocellulose paper. The blots are then detected by enzymatically labelled or radiolabeled antibody probes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Western Blotting","conceptCode":"C16357","definition":"A laboratory procedure for the detection or identification of proteins or peptides that have been separated by gel electrophoresis and transferred onto nitrocellulose or other type of paper or nylon membrane. The proteins are then detected by reaction with enzymatically labeled or radiolabeled antibody probes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0367-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-06-02","modifiedBy":"ONEDATA","dateModified":"2006-06-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DA6A9BDB-74CD-B169-E040-BB89AD43700F","beginDate":"2006-06-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-04-15","modifiedBy":"ONEDATA","dateModified":"2013-04-15","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2229718","version":"1","preferredName":"Name","preferredDefinition":"The words or language units by which a thing is known.","longName":"C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F6EF4E2B-76AE-72C1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-05-16","modifiedBy":"ONEDATA","dateModified":"2005-05-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5F32266-BC84-1A1E-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-10-13","modifiedBy":"REEVESD","dateModified":"2013-04-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2939361","version":"1","longName":"DCTD (Division of Cancer Treatment and Diagnosis)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3263369","version":"1","longName":"Biomarker Abstraction","context":"NCIP"}]}],"AlternateNames":[{"name":"ENGLISH","type":"CONTEXT NAME","context":"CCR"}],"ReferenceDocuments":[{"name":"Assay Method","type":"Preferred Question Text","description":"Assay Method","url":null,"context":"CCR"}],"origin":null,"workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"E5F32266-BCAC-1A1E-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-13","endDate":"2015-04-06","createdBy":"REEVESD","dateCreated":"2004-10-13","modifiedBy":"TAYLORT","dateModified":"2020-10-06","changeDescription":"10.6.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED.; Data element has not been used in forms or classifications since creation in 2003.  Retired because of lack of community need.  DMR 4.6.2015","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}